ILEX MEDICAL (ILX.TA) Financials
ILX.TA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 948.6 million | 346.7 million |
| 2023-06-30 | 959.3 million | 356.4 million |
| 2023-03-31 | 901.5 million | 308.1 million |
| 2022-12-31 | 899.2 million | 286.1 million |
ILX.TA Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -81.7 million | ? |
| 2023-06-30 | 80.0 million | ? |
| 2023-03-31 | -30.2 million | ? |
| 2022-12-31 | 8.2 million | ? |
ILX.TA Net Income
| Date | Net Income |
|---|---|
| 2023-09-30 | 8.9 million |
| 2023-06-30 | 10.6 million |
| 2023-03-31 | 8.9 million |
| 2022-12-31 | 38.2 million |
ILX.TA Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | - | - | 47.2 million |
| 2023-06-30 | - | - | 47.6 million |
| 2023-03-31 | - | - | 48.4 million |
| 2022-12-31 | - | - | 50.3 million |
ILX.TA Shares Outstanding
ILX.TA Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 13.0 million | 2.5 million | 36.3 million | - |
| 2023-06-30 | 13.4 million | 2.2 million | 35.8 million | - |
| 2023-03-31 | 16.8 million | 2.5 million | 37.7 million | - |
| 2022-12-31 | 11.6 million | 2.3 million | 77.0 million | - |
ILX.TA Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 221.7 million | 166.5 million |
| 2023-06-30 | 214.9 million | 161.7 million |
| 2023-03-31 | 210.3 million | 151.6 million |
| 2022-12-31 | 232.8 million | 164.0 million |
ILX.TA
Price: ILA6,277
Dividend Yield: 0.00%
Forward Dividend Yield: 2.16%
Payout Ratio: 2998.90%
Dividend Per Share: 136.45 ILA
Earnings Per Share: 4.55 ILA
P/E Ratio: 10.56
Exchange: TLV
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 709.2 million
Average Dividend Frequency: 57
Years Paying Dividends: 4